These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 21466500)

  • 1. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.
    Verdejo-García A; Pérez-García M
    Psychopharmacology (Berl); 2007 Mar; 190(4):517-30. PubMed ID: 17136401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
    Lundqvist T
    Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
    Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
    Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-drug and marijuana use among adults who primarily used methamphetamine.
    Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
    J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
    Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
    Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding drug addiction: a neuropsychological perspective.
    Yücel M; Lubman DI; Solowij N; Brewer WJ
    Aust N Z J Psychiatry; 2007 Dec; 41(12):957-68. PubMed ID: 17999268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.